Pediatrix Medical Group (NYSE:MD) Sets New 12-Month High – Time to Buy?

Pediatrix Medical Group, Inc. (NYSE:MD) reached a new 52-week high during trading on Thursday. The stock traded as high as $28.67 and last traded at $28.58, with a volume of 43,353 shares changing hands. The stock had previously closed at $28.10.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Wall Street Zen upgraded shares of Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a report on Sunday, September 13th. UBS Group increased their price target on shares of Pediatrix Medical Group from $25.00 to $28.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. Truist Financial lifted their price objective on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $25.00 price objective on shares of Pediatrix Medical Group in a research report on Wednesday, August 5th. Finally, Jefferies Financial Group cut shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and upped their target price for the company from $27.00 to $28.00 in a report on Wednesday, August 19th. One analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $26.60.

Pediatrix Medical Group Stock Performance

The company has a debt-to-equity ratio of 0.45, a current ratio of 1.32 and a quick ratio of 1.32. The stock has a 50-day moving average price of $26.55 and a 200-day moving average price of $24.86. The company has a market capitalization of $2.40 billion, a price-to-earnings ratio of 14.13 and a beta of 0.61.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.59 by $0.04. Pediatrix Medical Group had a return on equity of 20.05% and a net margin of 8.96%. The business had revenue of $487.78 million for the quarter, compared to analyst estimates of $478.49 million. During the same period in the previous year, the firm earned $0.53 EPS. The firm’s revenue was up 4.1% compared to the same quarter last year. As a group, analysts forecast that Pediatrix Medical Group, Inc. will post 2.17 earnings per share for the current year.

Institutional Trading of Pediatrix Medical Group

A number of hedge funds have recently modified their holdings of MD. Keybank National Association OH boosted its holdings in shares of Pediatrix Medical Group by 2.0% during the 1st quarter. Keybank National Association OH now owns 22,941 shares of the company’s stock worth $491,000 after buying an additional 458 shares during the period. Nisa Investment Advisors LLC raised its holdings in Pediatrix Medical Group by 3.3% in the 3rd quarter. Nisa Investment Advisors LLC now owns 19,131 shares of the company’s stock valued at $492,000 after acquiring an additional 605 shares during the period. Concurrent Investment Advisors LLC raised its holdings in Pediatrix Medical Group by 4.0% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 28,384 shares of the company’s stock valued at $719,000 after acquiring an additional 1,087 shares during the period. EverSource Wealth Advisors LLC lifted its position in Pediatrix Medical Group by 77.7% during the first quarter. EverSource Wealth Advisors LLC now owns 2,515 shares of the company’s stock worth $54,000 after acquiring an additional 1,100 shares during the last quarter. Finally, Amundi lifted its position in Pediatrix Medical Group by 8.3% during the first quarter. Amundi now owns 15,744 shares of the company’s stock worth $337,000 after acquiring an additional 1,209 shares during the last quarter. Institutional investors and hedge funds own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc provides specialized physician-led healthcare services for women, infants and children. The company’s clinical offerings include neonatal and perinatal care, maternal-fetal medicine, pediatric medical subspecialties, pediatric hospitalist services and related services delivered in partnership with hospitals and healthcare systems.

Pediatrix-affiliated physicians and advanced practice providers generally work in hospital-based settings, including neonatal intensive care units, delivery rooms, pediatric units and outpatient practices.